TRAITEMENT DU CANCER DU SEIN CHEZ LA FEMME AGEE PAR RADIOTHERAPIE HYPOFRACTIONNEE PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download TRAITEMENT DU CANCER DU SEIN CHEZ LA FEMME AGEE PAR RADIOTHERAPIE HYPOFRACTIONNEE PDF full book. Access full book title TRAITEMENT DU CANCER DU SEIN CHEZ LA FEMME AGEE PAR RADIOTHERAPIE HYPOFRACTIONNEE by Philippe Lopez. Download full books in PDF and EPUB format.
Author: Philippe Lopez
Publisher:
ISBN:
Category :
Languages : fr
Pages :
Get Book Here
Book Description
Author: Philippe Lopez
Publisher:
ISBN:
Category :
Languages : fr
Pages :
Get Book Here
Book Description
Author: Sandrine Romanet
Publisher:
ISBN:
Category :
Languages : fr
Pages : 164
Get Book Here
Book Description
Le cancer du sein est l'affection tumorale la plus fréquente chez la femme en France. Un tiers se développe chez des femmes de plus de 70 ans. La radiothérapie est une alternative, lorsque la chirurgie est contre-indiquée. La fréquence des séances peut néanmoinsêtre un facteur limitant. La radiothérapie hypofractionnée semble représenter un choix préservant la qualité de vie de ces patientes agées. Notre travail s'est donné pour objectifs d'évaluer la radiothérapie hypofractionnée exclusive comme traitement curatif en terme d'efficacité sur la progression tumorale et la survie et d'étudier ses effets secondaires. La première partie a relaté les particularités cliniques et biologiques du cancer du sein chez la femme agée et les traitements qui pouvaient lui être proposés. La deuxième partie a concerné l'étude de 115 patientes dont l'âge moyen était de 82.7 ans, porteuses de cancers du sein primitifs de stade1 à 3, traitées au Centre Antoine Lacassagne par radiothérapie hypofractionnée exclusive associée à une hormonothérapie entre 1987 et 1999. Nos résultats montrent que la radiothérapie hypofractionnée exclusive associée à l'hormonothérapie peut être une proposition thérapeutique raisonnable pour des patientes très âgées ou inopérables.
Author: PIA.. TOUBOUL LUNDGREN
Publisher:
ISBN:
Category :
Languages : fr
Pages : 124
Get Book Here
Book Description
Author: Dominique Lefèbvre
Publisher:
ISBN:
Category :
Languages : fr
Pages :
Get Book Here
Book Description
Author: Aung Naing
Publisher: Springer Nature
ISBN: 3030793087
Category : Medical
Languages : en
Pages : 445
Get Book Here
Book Description
The field of immuno-oncology continues to rapidly evolve as new insights to fight and treat cancer emerge. The fourth edition of Immunotherapy provides the most current overview of immuno-oncology in different cancer types and toxicities associated with immunotherapy. While immunotherapy has revolutionized the treatment landscape of several solid malignancies, several challenges still exist. Only a subset of patients derive clinical benefits; some do not respond at all, and others respond initially, only for their disease to progress later. Because these drugs can activate a broad range of immune cells, patients suffer from a unique set of side effects known as immune-related adverse events. As more immunotherapeutic agents are used in the clinic, it is important to provide updates about current and ongoing developments in the field to further research efforts and inform treatment decisions. The fourth edition will have a new focus on strategies to overcome the challenges associated with immunotherapy. Chapters will discuss topics such as biomarkers of response, resistance mechanisms, role of imaging in predicting immune-related adverse events, and management of immune-related adverse events. Written by leading experts conducting cutting-edge research, readers will gain up-to-date knowledge on the current state and future of immunotherapy.
Author: H. F. Hope-Stone
Publisher: Butterworth-Heinemann
ISBN:
Category : Medical
Languages : en
Pages : 474
Get Book Here
Book Description
Author: Paul Kleihues
Publisher:
ISBN:
Category : Medical
Languages : en
Pages : 326
Get Book Here
Book Description
The second edition of this concise reference book was prepared by 106 authors from 21 countries and covers the neuro-oncological literature until January 2000. Diagnostic criteria, pathological features and associated genetic alterations are described in a strictly disease-oriented manner. Sections on more than 70 neoplasms and their variants include ICD-O codes, incidence, age and sex distribution, location, clinical signs and symptoms, pathology, genetics and predictive factors. New disease entities include the chordoid glioma of the third ventricle and the cerebellar liponeurocytoma. Inherited tumor syndromes involving the nervous system are dealt with in a separate chapter, combining diagnostic criteria, pathology and genetics.
